• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Candriam Equities L Biotechnology

+ Add to Watchlist

DXBLU:LX

507.8300 USD 0.00000.00%

As of 07:42:05 ET on 11/27/2014.

Snapshot for Candriam Equities L Biotechnology (DXBLU)

Open: - High - Low: - Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 355.1600 - 507.8300 Beta vs BTK: 0.8588

ETF Chart for DXBLU

No chart data available.
  • DXBLU:LX 507.8300
  • 1D
  • 1M
  • 1Y
507.8300
Interactive DXBLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DXBLU

Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for DXBLU

NAV -
Assets (M) (on 2014-11-26) 675.5596
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for DXBLU

No dividends reported

Performance for DXBLU

1-Month +6.92% 1-Year +38.14%
3-Month +11.70% 3-Year +46.36%
Year To Date +35.33% 5-Year +30.98%
Expense Ratio -

Top Fund Holdings for DXBLU

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 510,000 54,289,500 8.919%
Celgene Corp 570,000 54,024,600 8.875%
Amgen Inc 345,000 48,458,700 7.961%
Biogen Idec Inc 114,000 37,712,340 6.195%
Alexion Pharmaceuticals Inc 180,000 29,847,600 4.903%
Regeneron Pharmaceuticals Inc 71,000 25,596,920 4.205%
Vertex Pharmaceuticals Inc 200,000 22,462,000 3.690%
Illumina Inc 110,000 18,031,200 2.962%
BioMarin Pharmaceutical Inc 198,000 14,287,680 2.347%
Salix Pharmaceuticals Ltd 80,000 12,499,200 2.053%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil